Skip To Main Content
Gunter F Egger on Muck Rack

Gunter F Egger

As seen in: Nature, Archives of Disease in Childhood
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gunter F

Contact Gunter F, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A roadmap for therapeutic innovation in paediatric chronic kidney disease

|
By Mandy Wan, Rukshana Shroff, Detlef Bockenhauer, Maria Cavaller-Bellaubi, Gunter F Egger, Olivia Boyer, Jérôme Harambat, Tim Friede, Susie Gear, Oliver Gross, Frank Holtkamp, Laura H. Mariani, Jennifer Mckenzie, Louise Oni, Kelly Plueschke, Svenja Seide, Saskia de Wildt, Giovanni Montini, Nicholas Webb, Julie R. Ingelfinger, Gilles Vassal, Franz Schaefer, Gordana Atanackovic, Susana Carvajal Arjona, Sabine Scherer, Marvin Sinsakul
| Nature Verified
Abstract Paediatric chronic kidney disease (CKD) is a progressive and life-altering condition that is associated with substantial comorbidities, reduced life expectancy and considerable burdens on children, families and health care systems. Despite advances in supportive medical management, therapeutic development in paediatric CKD remains sparse.
Open in Who Shared Issue with article?

Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process

|
By Angeliki Siapkara, Claudio Fracasso, Gunter F Egger, Carmelo Rizzari
| Archives of Disease in Childhood Verified
Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process 1 VRNN, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK 2 Pediatric Centre of Excellence, Pfizer S.r.l, Rome, Italy 3 Scientific Evidence Generation Department, European Medicines Agency, Amsterdam, Netherlands 4 Department of Paediatrics, University of Milan–Bicocca, Milano, Italy...
Open in Who Shared Issue with article?

Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process

|
By Carmelo Rizzari, Angeliki Siapkara, Claudio Fracasso, Gunter F Egger
| Archives of Disease in Childhood Verified
Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process 1VRNN, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK 2Pediatric Centre of Excellence, Pfizer S.r.l, Rome, Italy 3Scientific Evidence Generation Department, European Medicines Agency, Amsterdam, Netherlands 4Department of Paediatrics, University of Milan–Bicocca, Milano, Italy...
Open in Who Shared Issue with article?
See all 3 articles